WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert alopecia areata the belgravia centre 17 09 2018A new entry has just been added to Belgravia’s Alopecia Areata Treatment Success Stories gallery.

Ms T, pictured, has responded really well to the treatment plan recommended by her specialist.

Read her Belgravia Centre review and see her regrowth results close up, or find out more about treating patchy hair loss from Alopecia Areata by clicking the relevant button below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 

 


The Belgravia Centre Hair Loss ClinicThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Jake

Question: I can’t use minoxidil or finasteride due to side effects. Are there any other options?

Answer: Hi, Jake. Due to the medications you mention we are assuming you are looking for alternative treatments for Male Pattern Baldness.

Minoxidil and finasteride 1mg are currently the only clinically-proven, MHRA licensed and FDA approved hair loss treatments for this condition. As the side effect profile of minoxidil is generally considered to be low, we would recommend speaking to a hair loss specialist to ensure you have explored and exhausted all options available to you here. They will be able to recommend suitable formulations based on your medical profile as well as your level and pattern of shedding, and answer any questions you may have about them.

If you still prefer to avoid these established medications, there are two routes you could consider: hair restoration surgery or non-pharmaceutical hair growth ‘boosters’.

Mens Hair Loss Treatment Male Pattern Baldness Belgravia CentreDepending on your age, how extensive your hairloss is and your medical suitability, a hair transplant may be worth considering. This surgery involves having donor hairs harvested from the areas of the scalp that are not affected by Male Pattern Baldness, namely the back and sides (only the hairs located along the top of the scalp, from the crown to the hairline and temples are susceptible to genetic hair thinning).

One important point about this option, and one a reputable surgeon should discuss with you if you choose to explore this route, is how the operation often goes hand-in-hand with pharmaceutical treatment use. Many hair restoration experts recommend following a male hair loss treatment course for at least six months prior to the procedure. This is to maximise hair growth and minimise shedding, making the area cleaner to work with.

The course is generally resumed following the op as part of an aftercare and upkeep hair regimen. The reason for this is that the original hairs in the susceptible areas surrounding those replaced during transplantation will remain subject to the effects of DHT – the hormone which binds to the vulnerable follicles, causing gradual weakening, thinning hair and hair loss or baldness in the affected areas. For instance, if a man has a hair transplant to fill out a receding hairline, even though these implanted hairs should be immune to Male Pattern Baldness and start to show their final results around 12 months after surgery, he may still experience shedding along his vertex and/or crown area.

Another avenue you may wish to explore is the world of secondary or supplementary therapies. These are generally used to best effect alongside the appropriate hair loss medications but can also be used on their own. Whilst unproven therapies such as scalp injections – PRP and mesotherapy – fall under this category, there are a range of non-invasive hair growth supporting products that Belgravia hair specialists prefer to recommend.

This includes LLLT devices such as the FDA-cleared LaserBand which uses laser diodes to stimulate the hair follicles to encourage hair growth, but we would suggest having a consultation first to ensure whichever options you decide to try are suitable for you.

One thing you can do, in the meantime, is to ensure you are reducing the number of hair loss triggers – factors which can exacerbate shedding – such as stress, a poor or unbalanced diet and smoking. Whilst these steps won’t stop hair loss where the cause is purely genetic, they may help by not aggravating the condition or speeding up the rate at which you are losing your hair.


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 13 09 2018A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Constantine, pictured, has seen dense regrowth since starting his personalised treatment course.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Just ten days after announcing having been awarded a Breakthrough Therapy designation by America’s Food and Drug Administration (FDA) for its novel Alopecia Areata treatment, Pfizer has revealed the results of its latest trial.

These were announced on 15th September 2018 as part of the 27th European Academy of Dermatology and Venereology (EADV) Congress in Paris, France.

PfizerHair regrowth improvements

The multi-centre, blind Phase 2a clinical trial was conducted in a compared the effects of an oral janus kinase inhibitor (JAK inhibitor) known as PF-06651600, and a tyrosine kinase inhibitor referred to as PF-06700841, to a placebo in order to determine their hair regrowth capabilities. The trial participants all had confirmed diagnoses of autoimmune hair loss from moderate rounded bald patches of the scalp only (Alopecia Areata), to the most severe phenotype which presents as complete baldness from head to toe (Alopecia Universalis)

Although available Alopecia Areata treatment can be beneficial in cases of the localised scalp iteration – as many Belgravia clients have experienced – the more extensive the hair loss, the fewer and less effective current treatment options tend to be.

Trial volunteers were randomly split into three groups – one which received the JAK inhibitor PF-06651600, one which received the tyrosine kinase inhibitor PF-06700841 and one which received a placebo treatment.

The JAK inhibitor group was administered PF-06651600 in doses of 200 mg once per day for 4 weeks, then 50mg per day for 20 weeks. The PF-06700841 group were given the tyrosine kinase inhibitor in 60 mg per day doses for 4 weeks, followed by 30 mg daily for 20 weeks. Placebo doses were not provided but, equally, are irrelevant to the outcomes.

According to a press release circulated by the pharmaceutical giant, ‘the placebo-adjusted mean (95% CI) in SALT change from baseline scores at Week 24 were 33.6 points (21.4, 45.7), (P<0.0001) for PF-06651600 and 49.5 points (37.1, 61.8), (P<0.0001) for PF-06700841, with statistically significant separation from placebo occurring as early as Week 6 and Week 4, respectively.

Both JAK inhibitors met the primary efficacy endpoint in improving hair regrowth on the scalp relative to baseline at week 24 (33.6 points and 49.5 points for JAK3 and TYK2/JAK1, respectively) as measured by the Severity of Alopecia Tool (SALT) score (100 point scale).’

Diagram Belgravia Centre Different Types of Alopecia Areata autoimmune hair loss

Areas affected by Alopecia Areata hair loss are shown in blue

Although there were some side effects noted, these adverse events were deemed ‘comparable between treatment groups’, with the most commonly seen issues being gastrointestinal and skin/subcutaneous tissue infections.

Dr. Michael Vincent, M.D, Ph.D., Senior Vice President and Chief Scientific Officer at Pfizer Inflammation and Immunology stated, “This is the first well-controlled study of oral JAK inhibitors in alopecia areata, helping enhance our understanding of this disease with significant unmet need and advance the science of kinase inhibition.

Whether he meant the first study by Pfizer, or in general – given that other research institutions and pharmaceutical companies have been conducting clinical trials into JAK inhibiton‘s effect on alopecia areata hair loss for some years now – was not made clear.

Moving on to next clinical trial phase

These results relate to completion of Phase 2a of the clinical trial process, which typically constitutes four separate stages – three prior to release, with the fourth being post-release monitoring. Therefore, Phase III is the final stage that, following successful completion, enables the drug to be put forward for evaluation by the necessary medical regulatory boards in each country, such as the MHRA and FDA in the UK and USA respectively. Their licenses and approvals need to be obtained before the medication can be made available for prescription to patients in those locations.

Given Pfizer and the FDA are working together to expedite the development and review processes involved in trying to bring these new treatments to market, although the process can take many months or years in some cases, this is likely to be prioritised in order to release the medications as quickly as possible if they are proven to meet all safety, tolerability and efficacy criteria.

The FDA is also working in a similar way with two other pharmaceutical companies to Fast Track their novel treatments for Alopecia Areata, Alopecia Totalis and Alopecia Universalis. The estimated release date that at least one of these is working towards, has been given as 2021/2022.

In the meantime, those affected with this type of alopecia are advised to consult their GP and look into support from counsellors and hair loss charities if the baldness extends to the whole head – including facial hair – or body, or if they are under 16 years of age. For those aged 16 and over with the scalp-only phenotype, topical treatment for Alopecia Areata may be possible, so a consultation with a hair specialist is worth considering.


Circ - Belgravia Centre Taxi New StreetThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 12 09 2018A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Mr M, pictured, has seen increased hair growth since starting his personalised treatment plan.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Here at Belgravia we are frequently asked about platelet-rich plasma therapy, better known as PRP.

This novel procedure involves drawing a patient’s blood, spinning and separating it to obtain the most platelet-dense mixture, which is sometimes further enhanced with additives, then injecting it back into the patient’s scalp.

Originally used to accelerate wound-healing times in athletes, it found fame in recent years as an anti-ageing ‘Vampire Facial‘ treatment, before being explored as a potential way to treat hair loss.

PRP Therapy for Hair LossNow, researchers in the USA have published their findings following a systematic review of PRP as a genetic hair loss treatment, in the Facial Plastic Surgery medical journal.

Previous research doubted hair loss treatment benefits

Various clinical trials have been conducted to see whether PRP may be an effective alternative to pharmaceutical hair loss treatments in cases of Male and Female Pattern Baldness.

The consensus across studies thus far has lent towards PRP only being potentially beneficial when used as an adjunct therapy – products designed to support hair growth – when regular sessions of these scalp injections are undertaken in addition to the use of clinically-proven hair loss treatments. Researchers have generally been of the view that PRP doesn’t yet offer any meaningful advantage for hair regrowth when used as a standalone treatment.

Separate clinical trials carried out in various countries, including America and Spain, noted findings which showed PRP to be ineffective as a genetic hair loss treatment, but worth exploring further as a secondary therapy to be used alongside the established MHRA-licensed and FDA-approved medications.

The area PRP has shown to have more obvious success in, is the treatment of Alopecia Areata – an autoimmune disorder which causes varying degrees of hairloss. An Egyptian study found administering these injections helped promote hair regrowth and further investigations are currently underway to explore the therapy’s applications for both Alopecia Areata and for Cicatricial Alopecia, which cannot currently be treated.

Systematic review of PRP hair regrowth research

An American team from the Department of Otolaryngology, Massachusetts Eye and Ear in Boston, Massachusetts conducted a review of available data in June 2018 to get a general overview of how effective PRP had been found to be as a genetic hair loss treatment so far.

Given the volume of studies into PRP for Male and Female Pattern Hair Loss treatment, case reports were excluded and 24 studies – taken from the PubMed, Embase and Cochrane databases – were chosen for review. Of those selected, 21 used clinical criteria to diagnose the participants’ hair loss condition, and 3 used biopsy methods. Of the 24 studies, 8 were randomised control trials whilst 16 were ‘prospective cohort’.

The Bostonians’ review uncovered the following: “PRP was injected with or without the use of a numbing agent, and most studies performed multiple injections (three or more separated by several weeks). Twenty-one studies reported positive outcomes by objective criteria (88%), while three suggested that there was no clinical improvement, although in two of these studies patients still reported increased satisfaction. There were no complications reported other than transient edema/erythema and pain/headache associated with the procedure.”

This led them to conclude, “The existing literature suggests that PRP is a low-risk intervention to treat AGA associated with good patient satisfaction and objective improvements in outcomes. Further research is needed to optimize preparation and delivery methods as well as standardize measurements of clinical outcomes.”

Interestingly, even where no significant hair growth improvements were indicated, trial participants still reported ‘increased satisfaction’; this suggests a placebo effect may factor into people’s reactions to PRP outcomes.


circ - Mens and womens hair vitamins Hair Vitalics for Men Women Belgravia Centre hair growth supplementThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Sneha

Question: hi, in 2011 I had a hair fall problem. It got controlled after 3-4 months. since then I have no hair fall problem no thinning of hair but hair loss on mainly the crown which is not growing at the amount which it should. my partings are wider. is it androgenetic alopecia, as I researched, or is it something different?

Answer: Hi, Sneha. We would need to run through a proper consultation with you – in person or online – before providing you with a confirmed diagnosis of your hair loss condition. However, what you describe here does sound symptomatic of Female Pattern Hair Loss, also known as androgenic alopecia.

This occurs in women with an inherited sensitivity to a testosterone by-product known as dihydrotestosterone, or – more commonly – DHT. Once this genetic condition becomes active, any time following puberty, the DHT binds to the susceptible hair follicles. These are the ones located around the top of the scalp in the region from crown to hairline and temple areas.

It is a permanent hair loss condition which gets progressively worse over time, without intervention. In addition to a drop in volume and increased shedding, women most often notice signs, as you have done, such as their parting getting wider and their scalp becoming more visible on top. These are totally normal signs of hair loss from androgenic alopecia.

The fact that you had issues with temporary hair loss a few years ago may be related. Sometimes an episode of increased hair fall that lasts a few months, indicates something called Telogen Effluvium. This is often triggered by stress – physical or emotional – and in genetically predisposed individuals, can exacterbate exisiting cases of pattern hair loss or bring about its premature onset.

Either way, the important thing is to deal with your present situation. There are clinically-proven women’s hair loss treatments available and Belgravia offers customised courses tailored to your precise needs and medical profile. These generally comprise a key topical medication paired with supplementary hair growth supporting products which can be used at home.

The first step, before you make any decisions about how to proceed, however, is to have a professional hairloss consultation to establish the precise condition you are dealing with and to identify any exacerbating factors. For instance, if you regularly wear your hair in a style that is tightly fixed at your crown – such as a high ponytail, bun or plait – this could be causing breakage or Traction Alopecia.

Both can present in addition to Female Pattern Hair Loss, as well as on their own, and could account for thinning hair at your crown. The fact you are experiencing a widening of your parting in addition to the hairloss at your crown does still suggest a genetic element, but it is important to clarify if there are any other issues contributing to the problem. Once this has been done, a hair specialist can tailor a suitable course of treatment based on their findings.


Circle - The Belgravia Centre Hair Loss Clinic - Clinical Therapy TreatmentThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Dealing with any type of hair loss can be hard to come to terms with, emotionally. Whilst friends and family may prove valuable sources of comfort, for some it can be helpful to speak with people who have been, or are going through, the same issue.

Sunderland-based organisation, Woman Warriors by Panache Group is a peer support group for women with various forms of Alopecia Areata, the autoimmune disorder which has left many of them completely bald. This fantastic community was founded by Jolene Casey and inspired by teen model Elisha Appleby who started losing her hair to this enigmatic condition at 15 years of age.

sherrie hewsonIn addition to helping each other, raising alopecia awareness and boosting their confidence – as well as visibility – via events such as walking in fashion shows, the Woman Warrior by Panache Group also aims to raise £100,000 to create a dedicated ‘hair loss hub’ in the North-East.

Now Newcastle-born Benidorm actor Sherrie Hewson has given them her backing after a chance meeting at a radio station.

Celebrity ambassador

Local newspaper, the Chronicle reports how warrior woman and Benidorm fan Hannah McKay ran into Hewson, in town to promote Benidorm Live at the Theatre Royal, when they were both being interviewed on Radio Newcastle.

McKay, who started to lose her hair in July 2017 and now has patchy hairloss from the scalp-only form of Alopecia Areata, was there to discuss Alopecia Awareness Month. She approached Hewson and the pair got chatting.

The candid star then opened up about her own experience of stress-related hair loss which she said caused her to lose the hair around her hairline and at the sides of her head. Although she did not state which hair loss condition she was affected by, she did note that it cleared up following six months of treatment, during which she wore wigs for her TV work.

“I lost my hair through stress and I know what they are dealing with and what they are going through,” Sherrie Hewson told the Chronicle.

“I understand their emotion and how it feels. A woman’s hair is their crown and glory, it’s your femininity and to lose it is very stressful. I know what it’s like to look in the mirror, I know what they are experiencing. 

These women are embracing their hair loss and by doing that and understanding it, then that helps them cope. It’s brilliant what they are doing and I’m happy to put my name to it.” Continues below…

Warrior Women Panache Group Hair Loss Support Group North East Sunderland Newcastle UK alopecia areata

Loose Women helping to dispel hair loss ‘stigma’

It seems fitting that Sherrie Hewson would agree to be an ambassador for such an organisation given she is one of a number of Loose Women panellists to open up about their hair loss.

Nadia Sawalha has discussed being diagnosed with the genetic condition Female Pattern Hair Loss, on the daytime TV show, whilst Gloria Hunniford has explained both the issues she had with thinning hair and the attitude her late daughter, Carol Keating, took after losing her hair during chemotherapy for breast cancer.

The popular programme has given prime coverage to various hair loss issues over the years, with presenters advising they want to help to eradicate the perceived stigma about women’s hair loss. A sentiment both the Loose Women and Warrior Women have in common.

Find out more about Woman Warriors by Panache Group and donate to their Just Giving campaign, via wearepanachegroup.com


CIRC Hair Vitalics for Women hair growth supplements Belgravia Centre womens hair loss treatmentThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

alert male pattern hair loss the belgravia centre 13 09 2018A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Rory, pictured, is showing solid signs of improvement in the thinning areas since starting his personalised course.

Find out what he had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

 

VIEW SUCCESS STORY

TreatmenT information 

 


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


When it comes to treating the two most common forms of hair loss – Male Pattern Baldness and Female Pattern Hair Loss – there are only two clinically-proven medications.

These drugs – one oral and one topical (the oral tablet being for medically suitable men aged 18+ only) which are both licensed by the MHR and FDA-approved – are considered the frontline treatments for genetic hair loss. However, additional non-pharmaceutical hair growth supporting products can be used alongside these for a fully rounded approach.

At Belgravia this complementary range includes highly targeted one-a-day Hair Vitalics food supplements and various FDA-cleared low-level laser therapy (LLLT) devices, such as the LaserBand.

The latter involves the use of 82 laser diodes embedded in a headband, which emit low frequency laser light to the scalp. When used three times per week, for 90 seconds per area – so a total time of just over six minutes per session – has been shown to stimulate the hair follicles, encouraging hair growth. It is marketed by manufacturers HairMax as ‘the world’s fastest laser hair loss treatment’.

There are many wearable, cap or helmet-style LLT devices available, however, the teeth used in HairMax products are patented and help to part the hair, allowing the lasers to get to the scalp more easily.

Now, using the base LLLT technique, scientists in Korea have developed a new wearable hair regrowth device designed to help men and women with hair lossContinues below…

Photostimulation micro LED LLLT therapy device

Photostimulation hair loss device

According to study details published in the American Chemical Society’s Nano journal, researchers put together a flexible sheet of 900 vertical micro-light emitting diodes (μLEDs) which had a surface area smaller than a postage stamp and was 20 μm thick.

These were used on live mice with shaved backs to investigate the device’s hair regrowth. These were divided into three groups – shaved and treated with minoxidil administered via injection, shaved and treated with photostimulation only for 15 minutes per day for 20 days, shaved with no treatment (used as a control)

They claim the resulting hair growth device is more effective – based on the photostimulation mice showing a wider regrowth area and longer hairs compared to the other two groups – and less power-consuming than others, stating further that it did not become warm enough to cause any thermal skin damage.

Difference between LEDs and laser diodes

In a recent interview with Forbes magazine, HairMax founder David Michaels explained the difference between LEDs – such as those used in this new device – and laser diodes – the technology featured in HairMax devices.

LEDs are used for treatments on the first layer of the skin but you need the power of laser light to penetrate down to the second layer of the skin where hair follicles originate. Although they may look the same, lasers provide stronger, highly focused, and more intense light energy than LEDs.

Hair Loss Consultation Trichocheck at The Belgravia Centre

Our high quality lasers deliver columnated light to the follicles to more effectively reach and energize the follicle root and stimulate the growth factors of the follicle. LED devices put out dispersed light, which is not focused, and is spread out like a fan over the scalp.

Dispersed light does not penetrate or effectively reach the follicle when compared to lasers. HairMax lasers are densely distributed within our devices and are optimally spaced providing full and concentrated scalp coverage with a single wavelength.”

Which type of hair loss?

Whilst the results from this trial appear to be impressive, one key bit of information is missing – which hair loss condition is being treated? The reason this is so signification is that, whilst Male and Female Pattern Baldness are permanent, hereditary conditions that get progressively worse over time, thinning hair can also be caused by other temporary conditions which may otherwise clear up of their own accord within a few months.

In humans we can tell which condition – or conditions, as it is possible to have more than one simultaneously – is present due to the location of the shedding. Genetic hairloss affects the top of the scalp anywhere in the vertex region from hairline to crown, whilst temporary conditions such as Telogen Effluvium cause diffuse thinning from the whole scalp.

As the Korean trial involves shaved mice and simply refers to the condition they are treating as ‘alopecia‘ – the over-arching medical term for any kind of hair loss – the precise conditions this is intended to treat are unknown. As such, quite how compelling the results are is unclear.


circ - Belgravia Centre Hair Loss Clinic Laser TherapyThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories